Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 42% ± 16% | |
peripheral blood | 15 studies | 40% ± 13% | |
intestine | 8 studies | 30% ± 11% | |
kidney | 7 studies | 38% ± 12% | |
brain | 6 studies | 25% ± 8% | |
eye | 5 studies | 28% ± 13% | |
uterus | 5 studies | 42% ± 15% | |
bone marrow | 4 studies | 31% ± 10% | |
liver | 4 studies | 27% ± 8% | |
prostate | 4 studies | 40% ± 12% | |
breast | 4 studies | 50% ± 5% | |
placenta | 3 studies | 53% ± 15% | |
adrenal gland | 3 studies | 37% ± 12% | |
pancreas | 3 studies | 23% ± 3% | |
thymus | 3 studies | 61% ± 22% | |
lymph node | 3 studies | 52% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 3193.24 | 459 / 459 | 100% | 51.38 | 1118 / 1118 |
esophagus | 100% | 3317.33 | 1445 / 1445 | 100% | 38.81 | 183 / 183 |
lung | 100% | 2779.56 | 578 / 578 | 100% | 36.15 | 1155 / 1155 |
ovary | 100% | 2933.72 | 180 / 180 | 100% | 45.39 | 430 / 430 |
uterus | 100% | 3016.40 | 170 / 170 | 100% | 49.92 | 459 / 459 |
brain | 100% | 3431.98 | 2641 / 2642 | 100% | 63.57 | 705 / 705 |
bladder | 100% | 2824.57 | 21 / 21 | 100% | 40.15 | 503 / 504 |
prostate | 100% | 3065.19 | 245 / 245 | 100% | 34.70 | 501 / 502 |
thymus | 100% | 3019.64 | 653 / 653 | 100% | 40.38 | 603 / 605 |
stomach | 100% | 2133.37 | 359 / 359 | 100% | 29.61 | 285 / 286 |
intestine | 100% | 2782.56 | 966 / 966 | 100% | 30.95 | 525 / 527 |
liver | 100% | 1581.20 | 226 / 226 | 100% | 25.36 | 404 / 406 |
skin | 100% | 3743.40 | 1809 / 1809 | 99% | 38.25 | 469 / 472 |
kidney | 100% | 2853.30 | 89 / 89 | 98% | 27.34 | 887 / 901 |
pancreas | 99% | 1242.88 | 324 / 328 | 99% | 31.89 | 177 / 178 |
adrenal gland | 100% | 3017.87 | 258 / 258 | 98% | 31.83 | 225 / 230 |
adipose | 100% | 2920.63 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2637.34 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 48.99 | 29 / 29 |
muscle | 100% | 5904.74 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3255.09 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 41.00 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 30.51 | 1 / 1 |
heart | 99% | 1705.51 | 849 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 2464.47 | 914 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 22.07 | 77 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0050684 | Biological process | regulation of mRNA processing |
GO_0000184 | Biological process | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_0006417 | Biological process | regulation of translation |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0006406 | Biological process | mRNA export from nucleus |
GO_0008380 | Biological process | RNA splicing |
GO_2000622 | Biological process | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
GO_0016607 | Cellular component | nuclear speck |
GO_0035145 | Cellular component | exon-exon junction complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0043025 | Cellular component | neuronal cell body |
GO_0030425 | Cellular component | dendrite |
GO_0005829 | Cellular component | cytosol |
GO_1990501 | Cellular component | exon-exon junction subcomplex mago-y14 |
GO_0071006 | Cellular component | U2-type catalytic step 1 spliceosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0071013 | Cellular component | catalytic step 2 spliceosome |
GO_0005634 | Cellular component | nucleus |
GO_0003729 | Molecular function | mRNA binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RBM8A |
Protein name | Alternative protein RBM8A RNA-binding protein 8A RNA binding motif protein 8A RNA-binding protein 8A (Binder of OVCA1-1) (BOV-1) (RNA-binding motif protein 8A) (RNA-binding protein Y14) (Ribonucleoprotein RBM8A) |
Synonyms | Y14 MDS014 RBM8 HSPC114 |
Description | FUNCTION: Required for pre-mRNA splicing as component of the spliceosome . Core component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junctions on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. The EJC marks the position of the exon-exon junction in the mature mRNA for the gene expression machinery and the core components remain bound to spliced mRNAs throughout all stages of mRNA metabolism thereby influencing downstream processes including nuclear mRNA export, subcellular mRNA localization, translation efficiency and nonsense-mediated mRNA decay (NMD). The MAGOH-RBM8A heterodimer inhibits the ATPase activity of EIF4A3, thereby trapping the ATP-bound EJC core onto spliced mRNA in a stable conformation. The MAGOH-RBM8A heterodimer interacts with the EJC key regulator PYM1 leading to EJC disassembly in the cytoplasm and translation enhancement of EJC-bearing spliced mRNAs by recruiting them to the ribosomal 48S preinitiation complex. Its removal from cytoplasmic mRNAs requires translation initiation from EJC-bearing spliced mRNAs. Associates preferentially with mRNAs produced by splicing. Does not interact with pre-mRNAs, introns, or mRNAs produced from intronless cDNAs. Associates with both nuclear mRNAs and newly exported cytoplasmic mRNAs. The MAGOH-RBM8A heterodimer is a component of the nonsense mediated decay (NMD) pathway. Involved in the splicing modulation of BCL2L1/Bcl-X (and probably other apoptotic genes); specifically inhibits formation of proapoptotic isoforms such as Bcl-X(S); the function is different from the established EJC assembly. . FUNCTION: Core component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junctions on mRNAs. . |
Accessions | A0A023T787 ENST00000583313.7 [Q9Y5S9-1] ENST00000369307.4 [Q9Y5S9-2] A0A060D9J6 L8E9A7 ENST00000691760.1 [Q9Y5S9-1] Q9Y5S9 ENST00000632555.1 [Q9Y5S9-1] |